Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?-Reference-Cited by-同舟云学术

Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?

Published:2023-08-24 Issue:17 Volume:24 Page:13139
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Cambuli Valentina Maria¹,Baroni Marco Giorgio²³^ORCID

Affiliation:

1. Diabetology and Metabolic Diseaseas, San Michele Hospital, ARNAS Giuseppe Brotzu, 09121 Cagliari, Italy

2. Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy

3. Neuroendocrinology and Metabolic Diseases, IRCCS Neuromed, 86077 Pozzilli, Italy

Abstract

Research in the treatment of type 1 diabetes has been addressed into two main areas: the development of “intelligent insulins” capable of auto-regulating their own levels according to glucose concentrations, or the exploitation of artificial intelligence (AI) and its learning capacity, to provide decision support systems to improve automated insulin therapy. This review aims to provide a synthetic overview of the current state of these two research areas, providing an outline of the latest development in the search for “intelligent insulins,” and the results of new and promising advances in the use of artificial intelligence to regulate automated insulin infusion and glucose control. The future of insulin treatment in type 1 diabetes appears promising with AI, with research nearly reaching the possibility of finally having a “closed-loop” artificial pancreas.

Funder

Department MeSVA, University of L’Aquila, Italy

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/17/13139/pdf

Reference87 articles.

1. Diabetes Control and Complications Trial Research Group, Nathan, D.M., Genuth, S., Lachin, J., Cleary, P., Crofford, O., Davis, M., Rand, L., and Siebert, C. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 977–986.

2. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes;Nathan;N. Engl. J. Med.,2005

3. 6. Glycemic Targets: Standards of Care in Diabetes—2023;ElSayed;Diabetes Care,2023

4. Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D Exchange clinic registry;Miller;Diabetes Care,2015

5. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: A nationwide, register-based cohort study;Rawshani;Lancet,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 1 diabetes mellitus: retrospect and prospect;Bulletin of the National Research Centre;2024-04-19

2. Revolutionizing Diabetes Care: The Pivotal Role of Artificial Intelligence (Preprint);2023-10-28

3. Visual Design Of Artificial Pancreas Glucose Control Method;2023 International Annual Conference on Complex Systems and Intelligent Science (CSIS-IAC);2023-10-20